Harvard Medical School: Bench to Bedside
February 20, 2018
February 20, 2018
BOSTON, Massachusetts, Feb. 20 -- Harvard Medical School issued the following news:
The past two decades have brought unprecedented advances in the field of genetics, but translating these promising discoveries into new therapies has been somewhat challenging.
To help catalyze the development of meaningful therapies, Harvard Medical School is launching a new program aimed at educating pharma and biotech leaders on the latest advances in genetics and how to optimize them . . .
The past two decades have brought unprecedented advances in the field of genetics, but translating these promising discoveries into new therapies has been somewhat challenging.
To help catalyze the development of meaningful therapies, Harvard Medical School is launching a new program aimed at educating pharma and biotech leaders on the latest advances in genetics and how to optimize them . . .